ACE and Parkinson disease: The most widely studied of the mentioned genetic variants in the context of PD or cognitive impairment was the ACE I/D polymorphism which is responsible for a significant variance in ACE levels—the DD genotype results in two-fold higher plasma and tissue ACE levels than in the II carriers [24].